Field diffusion · Biology · Medicine

AlphaFold impact report links diffusion to publications, structures, and patents

A quantitative impact study of AlphaFold 2's links to publications, experimental structure submissions, disease-related work, clinical articles, and patent citations.

Summary

Innovation Growth Lab's AlphaFold 2 impact summary studies about 5 million publications, clinical articles, patents, and protein structures. It reports broad scientific reach and positive associations with experimental structure submissions, publication and citation measures, disease-related research, clinical-article citations, and patent citations.

AI role

AlphaFold 2 is measured as a predictive AI tool diffusing through structural biology and downstream biomedical research outputs.

Narrative role

This is high-signal downstream evidence for the timeline because it estimates field-level effects of a canonical AI-for-science system rather than only tracking the original breakthrough.

Caveat

The report emphasizes associations and scope limits; it cannot fully rule out selection effects, streetlight effects, or unmeasured negative impacts.

Event

Date: 2025-12-18
Timeline role: Notable
Progress relevance: Field impact
Validation: Downstream measured

Evidence

Report · Bibliometric analysis

Observed metrics

publications linked to AlphaFold 2: 550,000; Report's estimate of direct and indirect publication links.
articles incorporating AlphaFold 2 methodology: 218,000; Report's estimate of articles incorporating elements of AlphaFold 2 into methods.
experimental structure submission rate: 45%-49% increase; Reported increased rate for researchers building on AlphaFold 2.
patent citation likelihood: 22.6%-34.2% more likely; Reported for research and researchers building on AlphaFold 2.

Source: Innovation Growth Lab ↗